Genetic testing in women diagnosed with breast cancer decreases cost of care nationwide
Wednesday, April 24, 2019 - 11:10
in Health & Medicine
A new study suggests that Oncotype DX-guided treatment could reduce the cost for the first year of breast cancer care in the US by about $50 million (about 2 percent of the overall costs in the first year).